title: The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi.
abstract: The incremental cost effectiveness of an integrated care package (i.e., medical care including antiretroviral therapy (ART) and other services such as psychological and social support) for people living with HIV/AIDS was calculated in a not-for-profit primary health care centre in Bujumbura run by Society of Women against AIDS-Burundi (SWAA-Burundi), an African non-governmental organisation (NGO). Results are expressed as cost-effectiveness ratio 2007, constant US$ per disability-adjusted life year (DALY) averted. Unit costs are estimated from the NGO's accounting data and activity reports, healthcare utilisation is estimated from the medical records of a cohort of 149 patients. Effectiveness is modelled on the survival of this cohort, using standard calculation methods. The incremental cost of integrated care for people living with HIV/AIDS in the Bujumbura health centre of SWAA-Burundi is 258 USD per DALY averted. The package of care provided by SWAA-Burundi is therefore a very cost-effective intervention in comparison with other interventions against HIV/AIDS that include ART. It is however, less cost effective than other types of interventions against HIV/AIDS, such as preventive activities.
authors.affiliation: Agence Europeenne pour le Developpement et la Sante, Bruxelles, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Renaud
authors.forename: O
authors.initials: O
authors.lastname: Basenya
authors.forename: N
authors.initials: N
authors.lastname: de Borman
authors.forename: I
authors.initials: I
authors.lastname: Greindl
authors.forename: G
authors.initials: G
authors.lastname: Meyer-Rath
mesh_terms: D000328:Adult; D000553:Ambulatory Care / Q000191:economics; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D002063:Burundi; D003362:Cost-Benefit Analysis; D019033:Delivery of Health Care, Integrated / Q000191:economics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents